Status:
UNKNOWN
Determination of the Incidence of Endometriosis and or Adenomyosis in Patients Diagnosed With Polycystic Ovary Syndrome, or the Incidence of Polycystic Ovary Syndrome in Patients Diagnosed With Endometriosis and or Adenomyosis
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Collaborating Sponsors:
Engin Oral
Berna Dilbaz
Conditions:
Endometriosis
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-40 years
Brief Summary
The study was designed as a multicenter, prospective cross-sectional cohort study. The research population will consist of patients under the age of 40, diagnosed with endometriosis and/or adenomyosis...
Detailed Description
For the diagnosis of polycystic ovary syndrome, Rotterdam Criteria will be used. Hyperandrogenism will be determined clinically by Ferriman-Gallwey scoring, and biochemically by serum total testostero...
Eligibility Criteria
Inclusion
- Having been diagnosed with endometriosis by ultrasound or surgery(after diagnosed)
- Being a newly diagnosed endometriosis patient
- Not using any hormones or additional drugs
- Not having undergone ovarian surgery
- Patients diagnosed with PCOS according to the Rotterdam diagnostic criteria
Exclusion
- Previously diagnosed with endometriosis, medically or surgically patients receiving treatment
- Patients who have undergone ovarian surgery
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 20 2023
Estimated Enrollment :
2450 Patients enrolled
Trial Details
Trial ID
NCT04916171
Start Date
June 1 2021
End Date
January 20 2023
Last Update
August 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye), 34000